+499.5%
MRNA vs DUOL
-43.9%
+543.3%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | DUOL | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -2.7% | +0.5% | -1.4% |
| 7D | +5.5% | +5.1% | +0.4% | +4.1% |
| 30D | +158.7% | +14.1% | +144.6% | +152.1% |
| 3M | +182.1% | +41.5% | +140.6% | +171.9% |
| 6M | +151.8% | +60.6% | +91.2% | +139.5% |
| YTD | +393.6% | -12.0% | +405.5% | +404.0% |
| 1Y | +499.5% | -43.4% | +542.8% | +535.4% |
| All | +499.5% | -43.9% | +543.3% | +535.4% |
Cumulative growth
Daily Returns
Daily percentage return beside DUOL.
Daily Out/Under-Performance
Portfolio return minus DUOL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × DUOL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded DUOL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling